Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines.

Jaksch M, MĂșnera J, Bajpai R, Terskikh A, Oshima RG.

Cancer Res. 2008 Oct 1;68(19):7882-6. doi: 10.1158/0008-5472.CAN-08-0723.

2.

The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells.

Bidlingmaier S, Zhu X, Liu B.

J Mol Med (Berl). 2008 Sep;86(9):1025-32. doi: 10.1007/s00109-008-0357-8. Epub 2008 Jun 6. Review.

3.

Insight into the complex regulation of CD133 in glioma.

Campos B, Herold-Mende CC.

Int J Cancer. 2011 Feb 1;128(3):501-10. doi: 10.1002/ijc.25687. Review.

4.

CD133: molecule of the moment.

Mizrak D, Brittan M, Alison M.

J Pathol. 2008 Jan;214(1):3-9. Review.

PMID:
18067118
5.

Melanoma stem cells: the dark seed of melanoma.

Zabierowski SE, Herlyn M.

J Clin Oncol. 2008 Jun 10;26(17):2890-4. doi: 10.1200/JCO.2007.15.5465. Review.

PMID:
18539969
6.

AC133/CD133/Prominin-1.

Shmelkov SV, St Clair R, Lyden D, Rafii S.

Int J Biochem Cell Biol. 2005 Apr;37(4):715-9. Review.

PMID:
15694831
7.

Melanoma tumor cell heterogeneity: a molecular approach to study subpopulations expressing the embryonic morphogen nodal.

Seftor EA, Seftor REB, Weldon D, Kirsammer GT, Margaryan NV, Gilgur A, Hendrix MJC.

Semin Oncol. 2014 Apr;41(2):259-266. doi: 10.1053/j.seminoncol.2014.02.001. Epub 2014 Feb 7. Review.

Supplemental Content

Support Center